ASND Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ascendis Pharma A/S

Watchlist Manager

Watchlist

Price: 239.215 USD -3.42% Market Closed

Market Cap: $14.9B

	Ascendis Pharma A/S NASDAQ:ASND	DK
V	Volcano Bhd KLSE:VOLCANO	MY
	BW Energy Ltd OTC:BWEFF	BM
	Doximity Inc NYSE:DOCS	US
S	Singamas Container Holdings Ltd HKEX:716	HK
	Intermestic Inc TSE:262A	JP
A	Aktienbrauerei Kaufbeuren AG XMUN:ABK	DE
A	AAR Corp F:ARZ	US
P	Plasson Industries Ltd TASE:PLSN	IL
P	PostNL NV F:TNTC	NL
	Arca Continental SAB de CV BMV:AC	MX

Profitability Summary

Ascendis Pharma A/S's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

91%

Strong 3Y Average Gross Margin

86%

Gross Margin is Increasing

80% > 91%

Healthy Operating Margin

25%

Negative 3Y Average Operating Margin

-91%

Operating Margin is Increasing

-484% > 25%

Exceptional Net Margin

71%

Negative 3Y Average Net Margin

-100%

Net Margin is Increasing

-511% > 71%

Exceptional Free Cash Flow Margin

32%

Negative 3Y Average Free Cash Flow Margin

-85%

Free Cash Flow Margin is Increasing

-461% > 32%

Exceptional ROE

119%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-60%

ROIC is Increasing

-205% > 216%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.